Difference between revisions of "Goserelin (Zoladex)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m
Line 12: Line 12:
 
*[http://chemocare.com/bio/goserelin.asp Goserelin (Zoladex) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/goserelin.asp Goserelin (Zoladex) patient drug information (Chemocare)]</ref>
 
*[http://chemocare.com/bio/goserelin.asp Goserelin (Zoladex) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/goserelin.asp Goserelin (Zoladex) patient drug information (Chemocare)]</ref>
 
*[http://www.uptodate.com/contents/goserelin-patient-drug-information Goserelin (Zoladex) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/goserelin-patient-drug-information Goserelin (Zoladex) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/goserelin-patient-drug-information Goserelin (Zoladex) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/goserelin-patient-drug-information Goserelin (Zoladex) patient drug information (UpToDate)]</ref>
 +
 +
==History of changes in FDA indication==
 +
* 12/29/1989: Initial FDA approval (label not available on Drugs @ FDA)
  
 
==References==
 
==References==
Line 19: Line 22:
 
[[Category:GnRH agonists]]
 
[[Category:GnRH agonists]]
 
[[Category:Prostate cancer medications]]
 
[[Category:Prostate cancer medications]]
 +
 +
[[Category:Drugs FDA approved in 1989]]

Revision as of 18:17, 28 October 2014

General information

Class/mechanism: Gonadotropin-releasing hormone (GnRH) analog, inhibits pituitary gonadotropin secretion, which suppresses ovarian and testicular steroidogenesis[1][2]
Route: SC
Extravasation: n/a

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Diseases for which it is used

Patient drug information

History of changes in FDA indication

  • 12/29/1989: Initial FDA approval (label not available on Drugs @ FDA)

References